Glomerula Expression of Perlecan and Its Relation with Proteinuria

RAO Jia,XU Hong,SUN Li,ZHAO Zhong-hua
DOI: https://doi.org/10.3969/j.issn.1001-7399.2006.06.020
2006-01-01
Abstract:Purpose To determine the distribution and expression of perlecan in kidneys of children with nepthrotic syndrome and of adriamycin-induced nephrotic rats. Methods Immunohistochemical staining for perlecan was used to examine the expression and distribution of perlecan in kidneys of adriamycin-induced nephrotic rats (ADR) at 7, 14, 21 and 28 days after adriamycin injection. The correlation of urine protein and glomerular expression of perlecan was also analyzed. Immunohistochemical staining for perlecan was performed in renal biopsies from children with nephritic syndrome or hematuria, with analysis of the correlation of urine protein and foot process width with glomerular expression of perlecan. Results In ADR, the expression of perlecan along GBM decreased with the development of proteinuria. In children with different pathology, the glomerular expression of perlecan was significantly lower in MCD and FSGS compared with control; the glomerular expression of perlecan was significantly higher in MN than that of control. There was no difference between TBMN and control. The glomerular expression of perlecan was significantly lower in IgA nephropathy with proteinuria compared with that with hematuria (P0.01). In MCD, the glomerular expression of perlecan was correlated negatively with the ratio of urine protein and creatinine, but not with FWP. Conclusions The glomerular expression of perlecan decreases significantly in ADR and children with MCD, which is correlated with urine protein.
What problem does this paper attempt to address?